Clinical Outcome of Patients on Ceftazidime–Avibactam and Combination Therapy in Carbapenem-resistant Enterobacteriaceae-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Outcome of Patients on Ceftazidime–Avibactam and Combination Therapy in Carbapenem-resistant Enterobacteriaceae

Published:2021 Issue:7 Volume:25 Page:780-784
ISSN:0972-5229
Container-title:Indian Journal of Critical Care Medicine
language:en
Short-container-title:

Author:

Shah Anand,Nagvekar Vasant,Unadkat Vrajeshkumar P,Chavan Amol,Kohli Ruhi,Hodgar Shailendra,Ashpalia Aashita,Patil Niranjan,Kamble Rahul

Publisher

Jaypee Brothers Medical Publishing

Subject

Critical Care and Intensive Care Medicine

Link

https://www.ijccm.org/doi/pdf/10.5005/jp-journals-10071-23863

Reference19 articles.

1. 1. Escandon-Vargas K, Reyes S, Gutierrez S, Villegas MV. The epidemiology of carbapenemases in Latin America and the Caribbean. Expert Rev Anti-Infect Ther 2017;15(3):277–297. DOI: 10.1080/14787210.2017.1268918.

2. 2. Ben-David D, Kordevani R, Keller N, Tal I, Marzel A, Gal-Mor O, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 2012;18(1):54–60. DOI: 10.1111/j.1469-0691.2011.03478.x.

3. 3. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29(12):1099–1106. DOI: 10.1086/592412.

4. 4. Wattal C, Javeri Y, Goel N, Dhar D, Saxena S, Singh S, et al. Convergence of minds: for better patient outcome in intensive care unit infections. Indian J Crit Care Med 2017;21(3):154–159. DOI: 10.4103/ijccm.IJCCM_365_16.

5. 5. Calfee DP. Recent advances in the understanding and management of Klebsiella pneumoniae. F1000Res 2017;6:1760. DOI: 10.12688/f1000research.11532.1.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indian consensus on the management of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II);Expert Review of Anti-infective Therapy;2024-05-27

2. Ceftazidime-avibactam combination therapy versus monotherapy for treating carbapenem-resistant gram-negative infection: a systemic review and meta-analysis;Infection;2024-05-13

3. Addressing the Global Threat of Multidrug-Resistant Infections: The Role of Ceftazidime-Avibactam Revisited;Cureus;2024-05-13

4. The Clinical Efficacy of Adding Ceftazidime/Avibactam to Standard Therapy in Treating Infections Caused by Carbapenem-Resistant Klebsiella pneumonia with blaOXA-48-like Genes;Antibiotics;2024-03-16

5. Effectiveness of Ceftazidime-Avibactam in Gram-Negative Nosocomial Pneumonia: A Real-World Study in India;Cureus;2024-02-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3